4.5 Article

Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome

期刊

PATHOGENS
卷 12, 期 9, 页码 -

出版社

MDPI
DOI: 10.3390/pathogens12091125

关键词

antimicrobial resistance; AmpC-producing Enterobacterales; bloodstream infections

向作者/读者索取更多资源

This study aimed to assess the resistance determinants and therapy outcome of AmpC-producing Enterobacterales associated with bloodstream infections. The findings showed no difference in the prevalence of comorbidities and previous surgical procedures between resistant and susceptible isolates. No difference was reported in mortality rates. The study also revealed the distribution of antibiotic resistance patterns among different strains.
Bloodstream infections associated with AmpC-producing Enterobacterales are severe medical conditions which, without prompt and effective treatment, may have dire ramifications. This study aimed to assess whether certain comorbidities and previous surgical procedures coincide with resistance determinants of AmpC-producing Enterobacterales associated with bloodstream infections. Antibiotic resistance patterns and therapy outcome were also determined. The patients' data obtained revealed that the prevalence of recent surgical procedures, solid organ tumors, metabolic diseases, kidney and liver failure, and hematological malignancies do not differ between resistant and susceptible isolates of AmpC-producing Enterobacterales. Furthermore, no difference was reported in mortality rates. Regarding antibiotic resistance, 34.52% of isolates were confirmed to be resistant (AmpC hyperproduction, ESBL, or carbapenemase). More than one in five AmpC hyperproducers were reported amid Providencia spp., K. aerogenes, E. cloacae, and C. freundii. strains. Carbapenemases were mostly noted in Providencia spp. followed by M. morganii and K. aerogenes strains. Serratia marcescens had the highest proportion of ESBLsof ESBLs. Resistance to expanded-spectrum cephalosporins of Providencia spp. and K. aerogenes strains exceeded 50%, and resistance to meropenem over 10% was observed only in C. freundii strains. Enterobacterales' ever-growing resistance to antibiotics is becoming quite a challenge for clinicians and new treatment options are required.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据